Signaling networks in MS: a systems-based approach to developing new pharmacological therapies.

about

Differential Neuroproteomic and Systems Biology Analysis of Spinal Cord Injury Dynamics and heterogeneity of brain damage in multiple sclerosis.Identifying characteristic miRNAs-genes and risk pathways of multiple sclerosis based on bioinformatics analysis.

P2860

Q37076892-15996EAB-B07D-4F3B-8503-5957EE9B6E0F Q46259503-B7F8BE5E-773C-47BE-BA32-862E853E3C82 Q50052861-B8A8EA2A-032A-45CA-AA50-C09FCF54BFA5

P2860

Signaling networks in MS: a systems-based approach to developing new pharmacological therapies.

Item

http://www.wikidata.org/entity/Q38238962

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Signaling networks in MS: a sy ...... new pharmacological therapies.

@en

type

Item

label

Signaling networks in MS: a sy ...... new pharmacological therapies.

@en

prefLabel

Signaling networks in MS: a sy ...... new pharmacological therapies.

@en

P1476

Signaling networks in MS: a sy ...... new pharmacological therapies.

@en

P2093

Albert Zamora

http://www.w3.org/2001/XMLSchema#string

Dimitris Messinis

http://www.w3.org/2001/XMLSchema#string

Ekaterina Kotelnikova

http://www.w3.org/2001/XMLSchema#string

Elena Schwartz

http://www.w3.org/2001/XMLSchema#string

Gilad Silberberg

http://www.w3.org/2001/XMLSchema#string

Ilya Mazo

http://www.w3.org/2001/XMLSchema#string

Ioannis N Melas

http://www.w3.org/2001/XMLSchema#string

Jose Manuel Mas

http://www.w3.org/2001/XMLSchema#string

Laura Artigas

http://www.w3.org/2001/XMLSchema#string

Leonidas G Alexopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine

Signalling ballet in space and time

Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls.

A network analysis of the human T-cell activation gene network identifies JAGGED1 as a therapeutic target for autoimmune diseases

Fuzzy logic analysis of kinase pathway crosstalk in TNF/EGF/insulin-induced signaling.

Computational disease modeling - fact or fiction?

Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction.

Data integration and systems biology approaches for biomarker discovery: challenges and opportunities for multiple sclerosis.

Diagnosing the decline in pharmaceutical R&D efficiency.

P304

138-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1352458514543339

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264712714

http://www.w3.org/2001/XMLSchema#string

P698

25112814

http://www.w3.org/2001/XMLSchema#string

Signaling networks in MS: a systems-based approach to developing new pharmacological therapies.

about

P2860

P2860

Signaling networks in MS: a systems-based approach to developing new pharmacological therapies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698